Figure 1From: Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinomaOverall survival (Kaplan-Meier analysis). Median overall survival was 8.2 months for group with hypercoagulability, and 14.6 months for group with normal coagulation. Differences were significant (HR = .54, P = .0011).Back to article page